HUTCHMED (China) (HCM) Total Current Liabilities (2015 - 2025)
HUTCHMED (China) (HCM) reported Total Current Liabilities of $315.8 million for Q4 2025, down 7.76% quarter-over-quarter from $342.3 million in Q2 2025.
HUTCHMED (China) (HCM) Total Current Liabilities (2015 - 2025) Analysis & Trends
HUTCHMED (China) (HCM) has 11 years of Total Current Liabilities data on file, last reported at $315.8 million in Q4 2025.
- Total Current Liabilities for Q4 2025 came in at $315.8 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $315.8 million (changed N/A YoY), and the FY2025 annual result was $315.8 million, changed N/A from the prior year.
- Total Current Liabilities eased to $315.8 million in Q4 2025 per HCM's latest filing, from $342.3 million in the prior quarter.
- Over five years, Total Current Liabilities peaked at $373.3 million in Q2 2024 and troughed at $188.5 million in Q1 2021.
- A 5-year average of $310.7 million and a median of $321.9 million in 2022 frame the typical range for Total Current Liabilities.
- The sharpest annual moves came in 2021 and 2025: Total Current Liabilities jumped 107.49% in 2021, then dropped 8.29% in 2025.
- A 5-year view of Total Current Liabilities shows it stood at $311.7 million in 2021, then gained by 13.55% to $353.9 million in 2022, then dropped by 3.68% to $340.9 million in 2023, then advanced by 9.51% to $373.3 million in 2024, then fell by 15.41% to $315.8 million in 2025.
- Business Quant data shows HCM's Total Current Liabilities at $315.8 million in Q4 2025, $342.3 million in Q2 2025, and $373.3 million in Q2 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 13.53 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 2.05 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 599.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 831.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 1.66 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 599.50 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 618.78 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 333.17 Mn |
| 10 | HUTCHMED (China) | 1.16 Bn | -306.90 Mn | - | 315.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 315.78 Mn |
| Jun 30, 2025 | 342.35 Mn |
| Jun 30, 2024 | 373.29 Mn |
| Jun 30, 2023 | 340.86 Mn |
| Dec 31, 2022 | 353.90 Mn |
| Jun 30, 2022 | 321.86 Mn |
| Dec 31, 2021 | 311.66 Mn |
| Jun 30, 2021 | 247.72 Mn |
| Mar 31, 2021 | 188.52 Mn |
| Dec 31, 2020 | 158.40 Mn |
| Jun 30, 2020 | 119.39 Mn |
| Dec 31, 2019 | 113.10 Mn |
| Sep 30, 2019 | 105.35 Mn |
| Jun 30, 2019 | 110.61 Mn |
| Mar 31, 2019 | 101.33 Mn |
| Dec 31, 2018 | 85.48 Mn |
| Jun 30, 2018 | 84.58 Mn |
| Dec 31, 2017 | 104.60 Mn |
| Jun 30, 2017 | 96.84 Mn |
| Dec 31, 2016 | 95.12 Mn |